In closing its investigation of the Express Scripts-Medco merger, the FTC was following its own long history of taking a more tolerant approach than the Department of Justice’s Antitrust Division toward...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information: